Drhouse
Founded 2022 · 62 employees on LinkedIn · 2 known investors
Dr House offers telehealth services connecting patients with board-certified doctors via video visits for non-emergency conditions, with prescriptions sent to a pharmacy or delivered. It operates across all 50 US states and accepts insurance.
Also known as Dr House · DrHouse
Investors · 2
Company profile
researched Aug 2026DrHouse is an app-based telehealth company that connects patients with licensed U.S. physicians (MDs and DOs) through secure video visits. The service is available 24/7 across all 50 U.S. states and covers non-emergency medical needs, including diagnosis, treatment plans, prescriptions where clinically appropriate, prescription refills, lab test referrals and doctor's notes. Patients may connect with a physician on demand—the company states a connection in as fast as 15 minutes—or schedule a visit with a doctor of their choice.
Service lines advertised include virtual urgent care (upper respiratory infections, sinus infection, cold and flu, strep throat, COVID-19, food poisoning, back pain), virtual primary care and chronic condition management (asthma, hypertension, diabetes, arthritis, migraine, allergies, annual wellness visits), online dermatology, men's health (hair loss, erectile dysfunction, premature ejaculation, hemorrhoids), women's health (birth control, menopause, yeast infections, bacterial vaginosis, urinary tract infections, gynecology), weight loss, smoking cessation and lab tests. Prescription categories referenced include antibiotics, antivirals, antihistamines, beta blockers, antidepressants and anxiety medication.
The platform sets explicit clinical boundaries: it does not treat emergencies, does not prescribe controlled substances, does not guarantee prescriptions (they depend on the physician's evaluation), and requires patients to be physically located in the United States during a visit. Some conditions are noted as requiring in-person care. Website medical content is produced by an in-house medical content team and reviewed by MDs, PhDs, NPs and PharmDs under stated content-creation guidelines.
Business model
DrHouse operates a fully virtual, app-based care model with no physical clinics. Patients download the mobile app, create an account with basic information and medical history, select a physician by availability, specialty or rating, and hold a secure video consultation. Physicians diagnose, build treatment plans, issue prescriptions when medically appropriate, provide refills, order lab referrals through Labcorp, and issue doctor's notes for work or school. Prescriptions are routed to a patient's chosen pharmacy for pickup or, in supported areas, delivered the same day.
Per-visit consumer payments with insurance billing. Physician visits start from $0 for patients with accepted insurance; the self-pay price is $129 per visit. Accepted insurers listed include Aetna, Anthem, Blue Cross Blue Shield, Cigna, Humana, Medicare and United Healthcare. The site also references membership and visit credits.
Traction
The company reports availability in all 50 U.S. states with insurance accepted from major national carriers, a network of board-certified MD and DO physicians, and consumer app store reviews from iOS and Android users. Dr. Mike Hoaglin, MD, licensed in 10 states and previously Medical Director at Prairie Health and Clinical Scholar-in-Residence at Practice Fusion, serves as a Medical Director.
▸Full profile — market position, technology, go-to-market, geography
Market position
DrHouse competes in the U.S. direct-to-consumer telehealth market, offering virtual urgent care and primary care as an alternative to in-person urgent care, emergency room and primary care visits, with cost comparisons to those settings featured in its patient-facing materials.
DrHouse positions itself on speed and breadth of access: on-demand connection to a board-certified physician in as little as 15 minutes, 24/7 availability, patient-selected doctors, upfront pricing, insurance acceptance, and prescription home delivery in as little as one hour in supported ZIP codes. The company states its physicians are board-certified and trained at U.S. medical schools, and that care is delivered entirely virtually without physical clinics.
Technology
Mobile applications for iOS and Android supporting account creation, physician selection, secure video consultations, electronic prescribing to pharmacies, in-app follow-up scheduling, lab referrals and care-assistant chat.
Go-to-market
Direct-to-consumer acquisition through the company website and mobile apps on the Apple App Store and Google Play, with a web sign-up flow that texts prospective patients a link to download the app. The site also references channels for employers, brokers, an affiliate program and a referral program.
U.S. consumers seeking non-emergency medical care remotely, including insured and self-pay patients, families and pediatric patients, plus employer channels referenced on the site.
Geography
United States only; the service is available in all 50 states, and patients must be physically located in the U.S. during a visit. Same-day or one-hour prescription delivery is limited to supported ZIP codes, with pharmacy pickup offered elsewhere.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 7
primary sources listed
- Drhousedrhouse.com · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Drhouse do?
- App-based telehealth service offering 24/7 video visits with licensed U.S. physicians, prescriptions and Rx delivery in all 50 states.
- Who are Drhouse's investors?
- Drhouse's investors include Specialist VC, Trind Ventures.